Latest Stock Split Details
Key information about Gilead Sciences, Inc.'s most recent stock split
Split Date: 2013-01-28
Split Ratio: 2:1
Price Before Split: $78.88
Price After Split: $39.44
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 2.00 times more shares (a 2:1 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Gilead Sciences, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2013-01-28 | 2:1 | No | $78.88 | $39.44 |
| 2007-06-25 | 2:1 | No | $77.44 | $38.72 |
| 2004-09-07 | 2:1 | No | $69.20 | $34.60 |
| 2002-03-08 | 2:1 | No | $72.16 | $36.08 |
| 2001-02-22 | 2:1 | No | $63.36 | $31.68 |
About Gilead Sciences, Inc.
Company overview and industry information
Gilead Sciences, Inc. (GILD) operates in the Drug Manufacturers - General industry. The recent 2-for-1 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Drug Manufacturers - General
Go to Gilead Sciences, Inc. Summary